Showing results (241-250 of 303) with videos related to
Sort By:
Pageof 31
Cell Host & Microbe|June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer ProtectionCarole J Henry Dunand, Paul E Leon, Min Huang, et al.Antiviral Research|March 16, 2022
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020Elena A Govorkova, Emi Takashita, Rod S Daniels, et al.Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.Science Immunology|August 6, 2017
Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responsesJingxian Zhao, Abeer N Alshukairi, Salim A Baharoon, et al.The Journal of Infection|March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in AustraliaNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.Mbio|July 21, 2022
Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory ExerciseJessica A Belser, Eric H Y Lau, Wendy Barclay, et al.Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.Pageof 31